{"schema_version":"1","generated_at":"2026-10-30T12:47:39.566Z","data_as_of":null,"url":"https://www.findmykol.com/kol/michael-ryan-ca-2","json_url":"https://www.findmykol.com/kol/michael-ryan-ca-2/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"michael-ryan-ca-2","name":"Michael Ryan","credential":"MD","specialty":"Pulmonary Disease","specialty_raw":"Pulmonary Disease","therapeutic_area":"Respiratory","therapeutic_areas":["Respiratory"],"city":"San Luis Obispo","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1700863511"},"summary":"Michael Ryan is a Respiratory physician.","overview":null,"focus":{"indications":[],"research_topics":["Respiratory"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Grifols USA, LLC","program_year":2021,"amount_usd":145.56,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700863511"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1700863511","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Genitourinary & hormones","share_pct":100,"classes_total":1,"classes":[{"class":"Phosphodiesterase 5 Inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Tadalafil","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2018,"last":2019},"rows_total":2,"shown":2,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"F31NS106827","title":"Investigating aberrant direct pathway striatal activity in parkinsonism and levodopa-induced dyskinesia","fiscal_year":2019,"amount_usd":"37055","organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/F31NS106827"},{"project":"F31NS106827","title":"Investigating aberrant direct pathway striatal activity in parkinsonism and levodopa-induced dyskinesia","fiscal_year":2018,"amount_usd":"36352","organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/F31NS106827"}],"source":"grants"},"contact":{"address_1":"1428 PHILLIPS LN STE 203","city":"San Luis Obispo","state":"CA","zip":"934012551","phone":"805-543-4407","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1700863511","source":"identity"},"similar":[{"name":"Fernando Martinez","slug":"fernando-martinez","institution":"University of Massachusetts Chan Medical School","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/fernando-martinez","json_url":"https://www.findmykol.com/kol/fernando-martinez/profile.json"},{"name":"David Gozal","slug":"david-gozal","specialty":"Pediatric Pulmonology","url":"https://www.findmykol.com/kol/david-gozal","json_url":"https://www.findmykol.com/kol/david-gozal/profile.json"},{"name":"Ronald Crystal","slug":"ronald-crystal","institution":"Weill Cornell Medicine","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/ronald-crystal","json_url":"https://www.findmykol.com/kol/ronald-crystal/profile.json"},{"name":"Bartolome Celli","slug":"bartolome-celli","institution":"Brigham and Women's Hospital","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/bartolome-celli","json_url":"https://www.findmykol.com/kol/bartolome-celli/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-11-03","provider_certified":"2023-11-03","collected_at":"2026-10-27T00:00:00.000Z"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}